Feinberg Peter 4
4 · Immuneering Corp · Filed Oct 1, 2025
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Feinberg Peter
Director
Transactions
- Purchase
Class A Common Stock
2025-09-30$7.03/sh+7,500$52,730→ 149,266 total
Holdings
- 476,615(indirect: By LLC)
Class A Common Stock
- 392,242(indirect: General Partner of PF Associates L.P.)
Class A Common Stock
- 115,441(indirect: By LLC)
Class A Common Stock
Footnotes (1)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $7.0049 to $7.055. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.